100 related articles for article (PubMed ID: 3106494)
1. The production of tumor necrosis factor by mouse bone marrow-derived macrophages in response to bacterial lipopolysaccharide and a chemically synthesized monosaccharide precursor.
Sayers TJ; Macher I; Chung J; Kugler E
J Immunol; 1987 May; 138(9):2935-40. PubMed ID: 3106494
[TBL] [Abstract][Full Text] [Related]
2. A monosaccharide precursor of Escherichia coli lipid A has the ability to induce tumor-cytotoxic factor production by a murine macrophage-like cell line, J774.1.
Amano F; Nishijima M; Akamatsu Y
J Immunol; 1986 Jun; 136(11):4122-7. PubMed ID: 3701065
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of endotoxin or lipid A-induced tumor necrosis factor production by synthetic lipid A partial structures in human peripheral blood mononuclear cells.
Wang MH; Flad HD; Feist W; Musehold J; Kusumoto S; Brade H; Gerdes J; Rietschel HT; Ulmer AJ
Lymphokine Cytokine Res; 1992 Feb; 11(1):23-31. PubMed ID: 1576244
[TBL] [Abstract][Full Text] [Related]
4. Lipopolysaccharide and tumor necrosis factor-alpha induce lipopolysaccharide receptor expression on bone marrow cells by different mechanisms.
Chaby R; Pedron T; Stütz PL; Girard R
J Immunol; 1993 Nov; 151(9):4476-85. PubMed ID: 7691950
[TBL] [Abstract][Full Text] [Related]
5. Granulocyte-macrophage colony-stimulating factor and IFN-gamma restore the systemic TNF-alpha response to endotoxin in lipopolysaccharide-desensitized mice.
Bundschuh DS; Barsig J; Hartung T; Randow F; Döcke WD; Volk HD; Wendel A
J Immunol; 1997 Mar; 158(6):2862-71. PubMed ID: 9058823
[TBL] [Abstract][Full Text] [Related]
6. Production of tumor necrosis factor by rIFN-gamma-primed C3H/HeJ (Lpsd) macrophages requires the presence of lipid A-associated proteins.
Hogan MM; Vogel SN
J Immunol; 1988 Dec; 141(12):4196-202. PubMed ID: 3143760
[TBL] [Abstract][Full Text] [Related]
7. Regulation of TNF-alpha release from bone marrow-derived macrophages by vitamin D.
Abu-Amer Y; Bar-Shavit Z
J Cell Biochem; 1994 Aug; 55(4):435-44. PubMed ID: 7962175
[TBL] [Abstract][Full Text] [Related]
8. Interferon-gamma enhances tumor necrosis factor-alpha production by inhibiting early phase interleukin-10 transcription.
Shakhov AN; Woerly G; Car BD; Ryffel B
Eur Cytokine Netw; 1996 Dec; 7(4):741-50. PubMed ID: 9010676
[TBL] [Abstract][Full Text] [Related]
9. Chemically detoxified lipid A precursor derivatives antagonize the TNF-alpha-inducing action of LPS in both murine macrophages and a human macrophage cell line.
Tanamoto K
J Immunol; 1995 Dec; 155(11):5391-6. PubMed ID: 7594555
[TBL] [Abstract][Full Text] [Related]
10. Acquired hyporesponsiveness to bacterial lipopolysaccharide and interferon-gamma in RAW 264.7 macrophages.
Boyte WR; Meals EA; English BK
Shock; 1996 Sep; 6(3):218-22. PubMed ID: 8885089
[TBL] [Abstract][Full Text] [Related]
11. Induction of tumor necrosis factor, IFN-gamma, and acute lethality in mice by toxic and non-toxic forms of lipid A.
Kiener PA; Marek F; Rodgers G; Lin PF; Warr G; Desiderio J
J Immunol; 1988 Aug; 141(3):870-4. PubMed ID: 3135314
[TBL] [Abstract][Full Text] [Related]
12. Modulation of lipopolysaccharide-induced cytokine gene expression in mouse bone marrow-derived macrophages by muramyl dipeptide.
Le Contel C; Temime N; Charron DJ; Parant MA
J Immunol; 1993 May; 150(10):4541-9. PubMed ID: 8482846
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-beta 1 primes macrophages for enhanced expression of the nitric oxide synthase gene for nitric oxide-dependent cytotoxicity against Entamoeba histolytica.
Lin JY; Seguin R; Keller K; Chadee K
Immunology; 1995 Jul; 85(3):400-7. PubMed ID: 7558128
[TBL] [Abstract][Full Text] [Related]
14. Induction of soluble antitumoral mediators by synthetic analogues of bacterial lipoprotein in bone marrow-derived macrophages from LPS-responder and -nonresponder mice.
Pfannes SD; Müller B; Körner S; Bessler WG; Hoffmann P
J Leukoc Biol; 2001 Apr; 69(4):590-7. PubMed ID: 11310845
[TBL] [Abstract][Full Text] [Related]
15. Reprogramming of lipopolysaccharide-primed macrophages is controlled by a counterbalanced production of IL-10 and IL-12.
Shnyra A; Brewington R; Alipio A; Amura C; Morrison DC
J Immunol; 1998 Apr; 160(8):3729-36. PubMed ID: 9558074
[TBL] [Abstract][Full Text] [Related]
16. Specific transcriptional inhibition of bone marrow-derived macrophage tumor necrosis factor-alpha gene expression and protein production using novel enantiomeric carbocyclic nucleoside analogues.
Bradshaw M; Rutherford MS; Hoeper BJ; McWhinney CD; Borcherding DR; Schook LB; Edwards CK
J Pharmacol Exp Ther; 1995 Jun; 273(3):1506-18. PubMed ID: 7791126
[TBL] [Abstract][Full Text] [Related]
17. Traces of bacterial lipopolysaccharide suppress IFN-gamma-induced nitric oxide synthase gene expression in primary mouse macrophages.
Bogdan C; Vodovotz Y; Paik J; Xie QW; Nathan C
J Immunol; 1993 Jul; 151(1):301-9. PubMed ID: 7686937
[TBL] [Abstract][Full Text] [Related]
18. ONO-4007, an antitumor lipid A analog, induces tumor necrosis factor-alpha production by human monocytes only under primed state: different effects of ONO-4007 and lipopolysaccharide on cytokine production.
Matsumoto N; Aze Y; Akimoto A; Fujita T
J Pharmacol Exp Ther; 1998 Jan; 284(1):189-95. PubMed ID: 9435177
[TBL] [Abstract][Full Text] [Related]
19. Reduced release of TNF and PCA from macrophages of tolerant mice.
Haslberger A; Sayers T; Reiter H; Chung J; Schütze E
Circ Shock; 1988 Oct; 26(2):185-92. PubMed ID: 3197264
[TBL] [Abstract][Full Text] [Related]
20. Regulation of inducible nitric oxide synthase messenger RNA expression and nitric oxide production by lipopolysaccharide in vivo: the roles of macrophages, endogenous IFN-gamma, and TNF receptor-1-mediated signaling.
Salkowski CA; Detore G; McNally R; van Rooijen N; Vogel SN
J Immunol; 1997 Jan; 158(2):905-12. PubMed ID: 8993010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
